"Atypical" virus discovered to be driver of certain kidney diseases

September 14, 2018, Medical University of Vienna
This image shows a cross section of a kidney. Credit: Holly Fischer/Wikipedia

An international research team led by Wolfgang Weninger has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy). This "atypical" virus, which the scientists named "MKPV" (for Mouse Kidney Parvovirus), belongs to the family of parvoviruses. The results of the study have now been published in the leading international journal Cell.

Background to the discovery: "Over the last few years, a spontaneous occurred in laboratory mice at our institute. Specifically, immunodeficient animals, that is to say animals with an inborn immune system disorder, were dying suddenly and prematurely from the condition. We were able to pinpoint the disease as a problem of the renal tubules," explains Weninger. And this so-called interstitial tubulopathy is triggered by MKPV. "MKPV-induced closely resembles a similar form of viral tubulopathy, which can occur in patients following a transplant," explains the MedUni Vienna immunology expert.

The researchers therefore have at hand a new model for studying viral kidney diseases, and . In contrast to previously used models, which are primarily based on surgical interventions or the administration of toxic substances, MKPV infection is a natural model, very similar to the chronic course of renal failure in humans. This model can now be used to test new drugs to combat renal fibrosis and tubulopathies. It will also be possible to discover new biomarkers for these diseases and develop them for clinical application.

Says Weninger: "Going forward, we will now be working on the question as to whether similar viruses also lead to kidney infections or in humans, especially in immunosuppressed patients following a ." The MKPV virus could also be used for the purposes of gene therapy, in order to repair genes in renal tubules. This is because MKPV infects very specific cells in the kidneys (renal tubules) but no other cells in the body. One could therefore use a non-infectious variant of the virus to deliver or replace genes in kidney cells.

About nephropathy

Nephropathy is a blanket medical term for various inflammatory and non-inflammatory kidney diseases. The commonest form is diabetic nephropathy. This is a condition whereby the kidneys can be damaged as a result of long-term diabetes. If blood glucose is poorly controlled over a period of many years, it ends up damaging the small blood vessels in the kidneys. However, nephropathy can also occur in connection with other diseases, such as high blood-pressure, or be caused by certain drugs or infections.

Explore further: Acute critical illness increases risk of kidney complications and death

More information: Ben Roediger et al. An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis, Cell (2018). DOI: 10.1016/j.cell.2018.08.013

Related Stories

Acute critical illness increases risk of kidney complications and death

September 10, 2018
Acute critical illness in people without previous renal disease puts them at risk of kidney complications as well as death, according to a study in published in CMAJ (Canadian Medical Association Journal).

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

Recent change in spectrum of HIV-linked kidney disease

December 14, 2017
(HealthDay)—The spectrum of HIV-associated kidney disease has changed with the improvement of therapy for HIV infection, according to a review article published in the Dec. 14 issue of the New England Journal of Medicine.

Study will test new treatments for life-threatening kidney condition IgA nephropathy

June 28, 2018
A patient from Birmingham is the first person to be recruited into a new worldwide study to test new treatments for a potentially life-threatening kidney condition called IgA nephropathy. The research team responsible for ...

Will blocking IL-17A help treat kidney disease?

January 22, 2016
Many different diseases and insults can injure kidneys, resulting in kidney failure. Some autoimmune diseases damage glomeruli (the 'filtering units' of the kidney), while problems with the tubules (for example, impaired ...

Research aims to prevent diabetic kidney failure

November 5, 2011
The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.

Recommended for you

Researchers explore new way of killing malaria in the liver

December 8, 2018
In the ongoing hunt for more effective weapons against malaria, international researchers said Thursday they are exploring a pathway that has until now been little studied—killing parasites in the liver, before the illness ...

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.